Loading…
The Archive · 1 posts
Innovate healthcare with Thalia Therapeutics (THAT)! 🌿 Unleashing novel therapies on LSE, promising strides in bioinnovation. 💡
Thalia Therapeutics acquires Sanmirna and raises £2.75M for Phase 1 AML therapy, adding clinical-stage RNA asset with 2027 data catalyst.
June 24, 2026
Showing 0 of 1 posts